Movement Disorders in Cabo Verde: Epidemiology, Access Barriers, and Public Health Implications in an Aging Island Population.
Movement Disorders in Cabo Verde: Epidemiology, Access Barriers, and Public Health Implications in an Aging Island Population.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Santa Barbara, US · Author affiliation
Department of Psychology, Santa Barbara City College, Santa Barbara, CA, United States.Location evidence
Providence, US · Author affiliation
Department of Medicine, Brown University, Providence, RI, United States.Location evidence
Coimbra, PT · Author affiliation
Center for Neuroscience and Cell Biology, Centre for Innovative Biomedicine and Biotechnology, Universidade de Coimbra, Coimbra, Portugal.Location evidence
Praia, CV · Author affiliation
Departamento de Neurologia, Hospital Universitário Agostinho Neto, Praia, Cabo Verde.Location evidence
A plain-language reading has not been prepared for this paper yet.
Original abstract
ObjectivesMovement disorders (MDs), including Parkinson's disease (PD) and essential tremor, are growing causes of disability globally. Yet, data on MDs in low- and middle-income countries (LMICs), including Cabo Verde, remain scarce. This study aimed to estimate MD prevalence and incidence, identify at-risk groups, and evaluate access to care.MethodsA multi-site, country-level cross-sectional study was conducted from July to December 2024, including 110 adults with confirmed MDs. Data were obtained via clinical record reviews, interviews, and a structured questionnaire. Analyses included descriptive statistics, multivariable logistic regression, and thematic analysis of open-text responses.ResultsThe age-standardized MD prevalence was 17 per 100,000 population (95% CI: 13-20), with higher rates in men [19 (14-25)] and in those over 60 [117 (89-145)]. PD accounted for 79% of cases. While 78% used pharmacotherapy, 70% faced moderate or severe difficulties accessing medication, and 35% of those who sought therapy reported facing barriers. Fifty-one percent experienced a significant life impact.ConclusionFindings reveal significant access challenges and rising MD burden, underscoring the need for early diagnosis, decentralized services, and public health system strengthening in LMICs.